Eli Lilly and Company's correction may be coming to an end as the actual demand for its drugs seems to be holding well. Learn more about LLY stock here.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Hims & Hers may leverage FDA compounding exemptions to further extend its compounded GLP-1 offerings. Learn why HIMS stock is ...

In this new role, she will take over the worldwide responsibility for the Informatics function for the Roche Group from Alan Hippe, who currently has the dual role of Chief Financial Officer (CFO) and ...

The U.S. Department of Labor is looking to phase out sheltered work programs that are allowed to pay disabled workers less ...

The widespread acceptance of the so-called GLP-1 drugs, Zepbound by Eli Lilly and Wegovy by Novo Nordisk, for weight loss has created a game-changing dynamic for the overall health of the 72% of ...

Eli Lilly & Co. faced a skeptical Seventh Circuit Tuesday in arguing a lower court used a misplaced two-step process when it ...

The soaring demand for antidiabetic and weight-loss drugs has lured in many biotech and big Pharma companies. Onto this ...

Minnesotans prescribed insulin won’t pay more than $35 per month for it, after the conclusion of a lawsuit against three ...

The projected fair value for Eli Lilly is US$1,419 based on 2 Stage Free Cash Flow to Equity The US$978 analyst price target ...

Buddy Teevens, a 1974 Silver Lake grad, went on to play and coach football at Dartmouth. 'The Buddy Way' premiers on ESPN2 on ...

Nicole Ryf President Kenosha Area Business Alliance 5500 6th Ave., Kenosha Employees: 7 kaba.org Nicole Ryf, president of the ...